Karyopharm Therapeutics, Inc. (KPTI)

NASDAQ: KPTI · IEX Real-Time Price · USD
4.60
+0.09 (1.88%)
Jul 1, 2022 12:08 PM EDT - Market open

Stock Price Forecast

According to 15 stock analysts, the average 12-month stock price forecast for KPTI stock is $12.62, which predicts an increase of 174.65%. The lowest target is $5.05 and the highest is $22.05. On average, analysts rate KPTI stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $5.05 $12.62 $12.24 $22.05
Change +9.90% +174.65% +166.38% +379.87%

Analyst Ratings

The average analyst rating for KPTI stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 444454
Buy 555555
Hold 556666
Sell 110000
Strong Sell 000000
Total 151515151615

Financial Forecast

Revenue This Year
167.69M
Decreased by -20.08%
Revenue Next Year
199.68M
Increased by 19.08%
EPS This Year
-2.15
EPS Next Year
-1.54
Year 2017201820192020202120222023202420252026
Revenue
1.61M30.34M40.89M108.09M209.82M167.69M199.68M248.43M296.52M361.01M
Revenue Growth
942.21%
1,790.09%
34.80%
164.31%
94.12%
-20.08%
19.08%
24.42%
19.36%
21.75%
EPS
-2.81-3.14-3.22-2.72-1.65-2.15-1.54-1.06-1.35-1.75
EPS Growth
----------
No. Analysts -----11111066

Revenue Forecast

Revenue 20222023202420252026
High 191.9M 250.7M 299.6M 311.4M 375.4M
Avg 167.7M 199.7M 248.4M 296.5M 361.0M
Low 141.0M 158.8M 190.4M 287.6M 350.2M

Revenue Growth

Revenue Growth 20222023202420252026
High
54.0%
49.5%
50.0%
25.3%
26.6%
Avg
34.5%
19.1%
24.4%
19.4%
21.7%
Low
13.2%
-5.3%
-4.6%
15.8%
18.1%

EPS Forecast

EPS 20222023202420252026
High -1.89 -0.86 -0.61 -1.42 -1.82
Avg -2.15 -1.54 -1.06 -1.35 -1.75
Low -2.42 -2.00 -1.72 -1.31 -1.70

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -